Inventor of 4-disease drug gets a boost thanks to ISRAEL21c
ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies
By ISRAEL21c —— Bio and Archives--July 17, 2019
Health and Medicine | Comments | Back To Full Article
It was our third most popular article in 2018, and it’s not hard to understand why: “One drug could treat Alzheimer, MS, Crohn’s disease and more” captured the attention of readers around the world.
“I received quite a high number of mails, mostly from patients or relatives of patients, for instance families of Alzheimer’s patients,” says Prof. David Naor of the Lautenberg Center for Immunology and Cancer Research at the Hebrew University of Jerusalem’s Faculty of Medicine.
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy